Cervarix, the cervical cancer vaccine from GSK, has been granted a licence by the Therapeutic Goods Administration (TGA) of Australia for the prevention of cervical cancer and precancerous lesions associated with the most common cancer-causing human papillomavirus types.
The bird flu situation in Bangladesh remains serious and the country will have to engage in a long-term strategic campaign against Highly Pathogenic Avian Influenza in order to get the spreading H5N1 virus under control, said the Food and Agriculture Organization of the United Nations (FAO).
Researchers retrospectively analyzed the effect of taking peginterferon and ribavirin (PI+R, hepatitis C treatment options) and PI+R plus a statin to measure the sustained viral response (SVR, negative virus in blood six months after the end of treatment) rate in hepatitis C patients.
Researchers have yet to report on the concept that hepatitis C virus (HCV) patients who take statins may experience improvements in alanine transaminase (ALT, liver enzymes) levels.
A lethal fish virus in the Great Lakes and neighboring waterways is approaching epidemic proportions, according to Paul Bowser, Cornell professor of aquatic animal medicine in the College of Veterinary Medicine.
A rapid diagnostic test capable of detecting and identifying viruses such as Dengue, Yellow Fever and Japanese encephalitis (JEV) has been developed that has significantly reduced the time and discomfort involved with diagnosing an infection.
Abbott (NYSE: ABT) and Celera (NYSE:CRA), an Applera Corporation business, announced that Abbott has received U.S. Food and Drug Administration (FDA) approval to market the Abbott RealTime HIV-1 viral load test for use on the company?s m2000? automated instrument system.
A total of 20 oral and poster presentations on clinical studies with Schering-Plough’s hepatitis products, including PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) combination therapy for chronic hepatitis C virus (HCV) infection, as well as boceprevir (SCH 503034), the company’s investigational oral HCV protease inhibitor currently in Phase II clinical development, will be presented by leading researchers at the 38th annual Digestive Disease Week (DDW) meeting to be held at the Washington Convention Center in Washington, D.C., May 20-23.
UT Southwestern Medical Center has joined a national clinical trial to identify the long-term health effects of West Nile virus infection and to learn more about the disease’s progression, symptoms and mortality.
The Elizabeth Glaser Pediatric AIDS Foundation has received a five-year, $9.7-million grant from the Bill & Melinda Gates Foundation to develop and test candidate vaccines to prevent HIV infection in children.